Reviewed by Dr Dan Reardon, NHS A&E doctor with a specialist interest in metabolic health. Published 23rd April 2026.
Most peptides being sold in the wellness market today have not been through the clinical trials required to prove they produce a meaningful effect in humans. A small number (most notably the GLP-1 class and the…
CJC-1295 has one of the strongest published human clinical records of any wellness-market peptide, a Phase 2 trial that was discontinued after a participant death, and a December 2024 FDA advisory committee vote against allowing it into the regulated compounding system. The gap between the science and the regulatory verdict is where its current safety…
BPC-157 is one of the most discussed peptides on the wellness internet and one of the least documented in the human clinical literature, and the gap between those two facts is where most of its safety story sits.
The compound has been studied in laboratories for more than thirty years. It has been studied in…
Zinc sulfide doesn’t show up in everyday health conversations. It doesn’t headline nutrition panels, nor does it make wellness trend forecasts. But behind the scenes, this humble compound is quietly powering a wide range of applications—from phosphorescent materials and optical devices to pigment bases and, in some cases, even skincare.
At first glance, it might…



